Ilya Pharma Overview

  • Founded
  • 2016
  • Status
  • Private
  • Employees
  • 15
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 8

Ilya Pharma General Information


Developer of next-generation biological drugs designed to treat wounds in skin and mucosa. The company's biological drug is a novel drug delivery system where lactic acid bacteria are used as vectors to produce and deliver biological drugs on-site to skin wounds or in the gastrointestinal tract, its human therapeutic proteins are delivered on-site in wounds by living lactic acid bacteria acting like small bioreactors, enabling patients with diabetes to get accelerated healing of a chronic wound in a cost-effective way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • St Göransgatan 23
  • 753 26 Uppsala
  • Sweden
+46 070-636 00 00

Ilya Pharma Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ilya Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Early Stage VC 17-Jan-2021 00.000 Completed Generating Revenue
9. Accelerator/Incubator 09-Jul-2020 00000 00.000 Completed Generating Revenue
8. Accelerator/Incubator 08-Jun-2020 00.000 00.000 Completed Generating Revenue
7. Accelerator/Incubator 04-Jun-2020 00.000 Completed Generating Revenue
6. Angel (individual) 01-Jan-2020 00.00 00.000 Completed Generating Revenue
5. Accelerator/Incubator 00000 Completed Generating Revenue
4. Grant 10-Sep-2018 00.000 00000 Completed Generating Revenue
3. Seed Round 10-Jul-2017 00000 00000 Completed Generating Revenue
2. Accelerator/Incubator 14-Jun-2017 Completed Generating Revenue
1. Grant 01-Mar-2017 Completed Generating Revenue
To view Ilya Pharma’s complete valuation and funding history, request access »

Ilya Pharma Executive Team (6)

Name Title Board Seat Contact Info
Evelina Vågesjö Ph.D Co-Founder & Chief Executive Officer
Peter Frank Chief Operating Officer
Stefan Roos Co-Founder & Chief Technology Officer
Mia Phillipson Co-Founder & Chief Scientific Officer
Oskar Lund Chief Financial Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Ilya Pharma Board Members (1)

Name Representing Role Since
Ingemar Kihlström Ph.D Ilya Pharma Chairman 000 0000
To view Ilya Pharma’s complete board members history, request access »

Ilya Pharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ilya Pharma Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Commission Government Minority 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Stockholms Affärsänglar Angel Group Minority 000 0000 000000 0
EIT Health Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »